Yeast species in the respiratory samples of COVID-19 patients; molecular tracking of Candida auris

被引:0
|
作者
Rouhi, Faezeh [1 ]
Soltani, Sajedeh [1 ]
Sadeghi, Somayeh [2 ]
Nasri, Elahe [2 ]
Hosseini, Mahnaz [3 ]
Ghafel, Safiyeh [3 ]
Aboutalebian, Shima [1 ,3 ]
Fakhim, Hamed [2 ]
Mirhendi, Hossein [1 ,3 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Med Parasitol & Mycol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Esfahan, Iran
[3] Isfahan Univ Med Sci, Mycol Reference Lab, Res Core Facil Lab, Esfahan, Iran
关键词
yeast species; respiratory mycobiome; COVID-19; Candida auris; colonization; CRITICALLY-ILL; TRACT; COLONIZATION; INFECTIONS;
D O I
10.3389/fcimb.2024.1295841
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Although the existence of Candida species in the respiratory tract is often considered commensal, it is crucial to recognize the significance of Candida colonization in immunocompromised or COVID-19 patients. The emergence of Candida auris as an emerging pathogen further emphasizes the importance of monitoring yeast infection/colonization, particularly in COVID-19 patients. Methods: In this study, respiratory samples mainly from COVID-19 patients, primarily those suspected of having a fungal infection, were cultured on Sabouraud dextrose agar plates and the yeast colonies were identified using a two-step multiplex PCR method. The samples suspected of C. auris underwent specific nested PCR followed by sequence analysis. Results: A total of 199 respiratory samples were collected from 73 women and 126 men, ranging in age from 1.6 to 88 years. Among the patients, 141 had COVID-19, 32 had cancer, 5 were hospitalized in ICU, 2 had chronic obstructive pulmonary disease)COPD(, and others were patients with combination diseases. From these samples, a total of 334 yeast strains were identified. C. albicans (n=132, 39.52%) was the most common species, followed by C. tropicalis (n=67, 20%), C. glabrata (n=56, 16.76%), C. krusei (n=18, 5.4%), C. parapsilosis (n=17, 5.08%), Saccharomyces cerevisiae (n=10, 3%), C. kefyr (n=9, 2.6%), C. dubliniensis (n=7, 2.1%), C. lusitaniae (n=5, 1.5%), C. auris (n=3, 0.9%), C. guilliermondii (n=2, 0.6%), C. rugosa (n=1, 0.3%), C. intermedia (n=1, 0.3%), and Trichosporon spp. (n=1, 0.3%). C. auris was detected in a patient in ICU and two COVID-19 patients. While its presence was confirmed through sequence analysis, our extensive efforts to isolate C. auris were unsuccessful. Conclusion: While C. albicans colonization remains prevalent, our study found no evidence of Candida lung infection. Since the role of Candida colonization in airway secretions remains ambiguous due to limited research, further studies are imperative to shed light on this matter.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Public health issues with Candida auris in COVID-19 patients
    Janniger, Edmund J.
    Kapila, Rajendra
    [J]. WORLD MEDICAL & HEALTH POLICY, 2021,
  • [2] A CASE OF HAFNIA ALVEI AND CANDIDA AURIS BLOODSTREAM INFECTION IN PATIENTS WITH COVID-19
    Gonuguntla, Varun Tej
    Clemen, Britney
    Lin, Susan
    [J]. CHEST, 2021, 160 (04) : 1728A - 1728A
  • [3] COVID-19 Hastalarinda Candida auris Infeksiyonlari: Bir Derleme
    Kilbas, Imdat
    Uzun, Meltem
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2023, 28 (01): : 11 - 18
  • [4] Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
    Villanueva-Lozano, Hiram
    Trevino-Rangel, Rogelio de J.
    Gonzalez, Gloria M.
    Teresa Ramirez-Elizondo, Maria
    Lara-Medrano, Reynaldo
    Cruz Aleman-Bocanegra, Mary
    Guajardo-Lara, Claudia E.
    Gaona-Chavez, Natalia
    Castilleja-Leal, Fernando
    Torre-Amione, Guillermo
    Martinez-Resendez, Michel F.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (05) : 813 - 816
  • [5] The impact of COVID-19 pandemic on invasive Candida auris infections in Kuwait
    Al-Wathiqi, Faten
    Alabdallah, Alaa
    Alobaid, Khaled
    [J]. MEDICAL MYCOLOGY, 2022, 60 (SUPP 1): : 102 - 102
  • [6] Candida auris Invasive Infections during a COVID-19 Case Surge
    Hanson, Blake M.
    Dinh, An Q.
    Tran, Truc T.
    Arenas, Sebastian
    Pronty, Darryl
    Gershengorn, Hayley B.
    Ferreira, Tanira
    Arias, Cesar A.
    Shukla, Bhavarth S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [7] Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit
    de Almeida, Joao N., Jr.
    Francisco, Elaine C.
    Hagen, Ferry
    Brandao, Igor B.
    Pereira, Felicidade M.
    Presta Dias, Pedro H.
    de Miranda Costa, Magda M.
    de Souza Jordao, Regiane T.
    de Groot, Theun
    Colombo, Arnaldo L.
    [J]. JOURNAL OF FUNGI, 2021, 7 (03)
  • [8] First Case of COVID-19 Positive Candida auris Fungemia in Turkey
    Bolukbasi, Yasemin
    Genc, Gonca Erkose
    Orhun, Gunseli
    Kuskucu, Mert Ahmet
    Cagatay, Atahan
    Onel, Mustafa
    Ongen, Betigul
    Agacfidan, Ali
    Esen, Figen
    Erturan, Zayre
    [J]. MIKROBIYOLOJI BULTENI, 2021, 55 (04): : 648 - 655
  • [9] Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic
    Dbeibo, Lana
    Beeler, Cole
    Clark, Lauren
    Zondor, Megan
    Sartino, Catherine
    Relich, Ryan F.
    Hazen, Dana
    Lyons, Kathy
    Kelley, Kristen
    Webb, Douglas
    Saysana, Michele
    Kara, Areeba
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2024, 52 (08) : 878 - 883
  • [10] The Menace of Candida auris Epidemic Amidst the COVID-19 Pandemic: A Systematic Review
    Najeeb, Hala
    Siddiqui, Sarush Ahmed
    Anas, Zahra
    Ali, Syed Hasan
    Usmani, Shajie Ur Rehman
    Jawed, Fareeha
    Jatoi, Hafsa Nazir
    [J]. DISEASES, 2022, 10 (03)